We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$2.82B
AUM Growth
+$380M
(+16%)
Cap. Flow
+$289M
Cap. Flow
% of AUM
10.23%
Top 10 Holdings %
Top 10 Hldgs %
47.61%
Holding
326
New
24
Increased
122
Reduced
122
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$160M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$65.1M |
| 3 |
RMIF
LHA Risk-Managed Income ETF
RMIF
|
+$29.8M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$17.3M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$16.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$21.8M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$17M |
| 3 |
Novartis
NVS
|
+$12.2M |
| 4 |
EA
Electronic Arts
EA
|
+$10.1M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$6.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 63.83% |
| 2 | Technology | 12.49% |
| 3 | Healthcare | 6.66% |
| 4 | Financials | 4.76% |
| 5 | Industrials | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pfizer
PFE
$157B
| $3.16M | 0.11% |
86,039
-3,640
| -4% | -$142K |
|
102
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $3.14M | 0.11% |
77,179
+1,785
| +2% | +$72K |
|
103
Mastercard
MA
$497B
| $2.92M | 0.1% |
7,434
-242
| -3% | -$90.8K |
|
104
iShares US Oil & Gas Exploration & Production ETF
IEO
$719M
| $2.92M | 0.1% |
34,427
-916
| -3% | -$76.9K |
|
105
Tesla
TSLA
$1.41T
| $2.68M | 0.09% |
10,224
+3,585
| +54% | +$717K |
|
106
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $2.59M | 0.09% |
65,468
-1,286
| -2% | -$50.6K |
|
107
iShares ESG Optimized MSCI USA ETF
SUSA
$3.99B
| $2.56M | 0.09% |
27,329
+401
| +1% | +$35.6K |
|
108
Stryker
SYK
$109B
| $2.54M | 0.09% |
8,340
-9
| -0.1% | -$2.6K |
|
109
Merck
MRK
$358B
| $2.53M | 0.09% |
21,946
-246
| -1% | -$27.9K |
|
110
Textron
TXT
$13.9B
| $2.48M | 0.09% |
+71,246
| New | +$4.7M |
|
111
Vanguard Dividend Appreciation ETF
VIG
$110B
| $2.41M | 0.09% |
14,840
-239
| -2% | -$37.4K |
|
112
iShares US Equity Factor ETF
LRGF
$3.65B
| $2.41M | 0.09% |
53,977
-4,183
| -7% | -$176K |
|
113
Illinois Tool Works
ITW
$76.1B
| $2.35M | 0.08% |
9,384
+70
| +0.8% | +$16.4K |
|
114
iShares Russell 2000 Value ETF
IWN
$14.1B
| $2.23M | 0.08% |
15,827
| – | – |
|
115
Idexx Laboratories
IDXX
$40.5B
| $2.22M | 0.08% |
4,425
+8
| +0.2% | +$3.83K |
|
116
NVIDIA
NVDA
$5.17T
| $2.2M | 0.08% |
52,110
+4,440
| +9% | +$147K |
|
117
Berkshire Hathaway Class A
BRK.A
$1.11T
| $2.07M | 0.07% |
4
| – | – |
|
118
Toronto Dominion Bank
TD
$198B
| $2.03M | 0.07% |
32,716
-362
| -1% | -$21.8K |
|
119
Home Depot
HD
$302B
| $1.99M | 0.07% |
6,401
+147
| +2% | +$43.4K |
|
120
IBM
IBM
$224B
| $1.96M | 0.07% |
14,666
+22
| +0.2% | +$2.84K |
|
121
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
| $1.9M | 0.07% |
+21,946
| New | +$1.87M |
|
122
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.6B
| $1.89M | 0.07% |
13,656
+16
| +0.1% | +$2.13K |
|
123
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
| $1.88M | 0.07% |
76,336
-8,747
| -10% | -$214K |
|
124
iShares Russell 1000 Growth ETF
IWF
$123B
| $1.88M | 0.07% |
27,272
+32
| +0.1% | +$2.04K |
|
125
Eli Lilly
LLY
$1.01T
| $1.83M | 0.07% |
3,907
-13
| -0.3% | -$5.45K |
|
Similar funds
CW
F
TYCC
AT
CCA
AF
FLSM
BT
Grimes & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Grimes & Company held 326 positions worth $2.82B, up 16% from $2.44B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Grimes & Company deployed $289M of net new capital in Q2 2023, opening 24 new positions and adding to 122 existing holdings. Its largest new stake was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $21.8M trimmed.
- Grimes & Company's largest Q2 2023 buy was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.
- Grimes & Company added most to iShares Russell 2000 ETF in Q2 2023, an estimated $160M increase.
- Grimes & Company's biggest Q2 2023 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $21.8M.
- Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q2 2023, selling an estimated $17M.
- Grimes & Company's ten largest holdings make up 48% of its $2.82B portfolio in Q2 2023.
- Grimes & Company opened 24 new positions and closed 11 in Q2 2023.
- Grimes & Company's portfolio value rose 16% quarter-over-quarter to $2.82B.
Based on Grimes & Company's 13F filing for Q2 2023, filed 19 Jul 2023.